154 related articles for article (PubMed ID: 38613349)
1. Fibroblast Growth Factor 23 is a Potential Prognostic Biomarker in Uterine Sarcoma.
Yang L; Cai Y; Wang Y; Huang Y; Zhang C; Ma H; Zhou JG
Technol Cancer Res Treat; 2024; 23():15330338241245924. PubMed ID: 38613349
[TBL] [Abstract][Full Text] [Related]
2. Identification of a RNA-seq-based signature to improve prognostics for uterine sarcoma.
Zhou JG; Zhao HT; Jin SH; Tian X; Ma H
Gynecol Oncol; 2019 Dec; 155(3):499-507. PubMed ID: 31662204
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and prognosis analysis of uterine sarcoma: a single-institution retrospective study.
Wang F; Dai X; Chen H; Hu X; Wang Y
BMC Cancer; 2022 Oct; 22(1):1050. PubMed ID: 36207687
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of tumor-size-stratified prognostic nomograms for patients with uterine sarcoma: A SEER database analysis.
Cao S; Liao X; Xu K; Xiao H; Shi Z; Zou Y; Li C; Hu Y; Yan S
Cancer Med; 2023 Jan; 12(2):1339-1349. PubMed ID: 35841316
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors and survival of patients with uterine sarcoma: a German unicenter analysis.
Huss A; Klar M; Hasanov MF; Juhasz-Böss I; Bossart M
Arch Gynecol Obstet; 2023 Mar; 307(3):927-935. PubMed ID: 35780401
[TBL] [Abstract][Full Text] [Related]
6. A novel nomogram for predicting cancer-specific survival in women with uterine sarcoma: a large population-based study.
Li YJ; Lyu J; Li C; He HR; Wang JF; Wang YL; Fang J; Ji J
BMC Womens Health; 2022 May; 22(1):175. PubMed ID: 35568940
[TBL] [Abstract][Full Text] [Related]
7. Uterine Sarcoma: Clinical Presentation, Treatment and Survival Outcomes in Thailand.
Potikul C; Tangjitgamol S; Khunnarong J; Srijaipracharoen S; Thavaramara T; Pataradool K
Asian Pac J Cancer Prev; 2016; 17(4):1759-67. PubMed ID: 27221849
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors, oncological treatment and outcomes of uterine sarcoma: 10 years' clinical experience from a tertiary care center in Pakistan.
Khan SR; Soomar SM; Asghari T; Ahmed A; Moosajee MS
BMC Cancer; 2023 Jun; 23(1):510. PubMed ID: 37277708
[TBL] [Abstract][Full Text] [Related]
9. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
[TBL] [Abstract][Full Text] [Related]
10. FGF23 Expression Is a Promising Immunohistochemical Diagnostic Marker for Undifferentiated Pleomorphic Sarcoma of Bone (UPSb).
Al-Hassi HO; Ali NM; Cooke H; De Silva S; Brini AT; Babu P; Sumathi V; Morris MR; Niada S
Genes (Basel); 2024 Feb; 15(2):. PubMed ID: 38397231
[No Abstract] [Full Text] [Related]
11. Wilms tumor gene 1 (WT1) is a prognostic marker in high-grade uterine sarcoma.
Coosemans A; Van Calster B; Verbist G; Moerman P; Vergote I; Van Gool SW; Amant F
Int J Gynecol Cancer; 2011 Feb; 21(2):302-8. PubMed ID: 21734473
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in patients with uterine sarcoma: the SARCUT study.
Zapardiel I; Gracia Segovia M; Macuks R; Mancari R; Achimas-Cadariu P; Corrado G; Bartusevicius A; Sukhin V; Muruzabal JC; Coronado Martín PJ; Gardella B; Piek JM; Concin N; Arab C; Papatheodorou D; Polterauer S; Iacoponi S; Nieto T; Lopez-Sanclemente MC; Trukhan H; Gil MM; Bakinovskaya I; Dalamanava A; Cucurull M; Rovski D; Baquedano L; Chiva L; Mardas M; Mavrichev SA; Klat J; Lopez de la Manzanara CA; Yildirim Y;
Int J Gynecol Cancer; 2023 Jun; 33(6):897-904. PubMed ID: 37192761
[TBL] [Abstract][Full Text] [Related]
13. Molecular prognostication of uterine smooth muscle neoplasms: From CGH array to CINSARC signature and beyond.
Croce S; Chibon F
Genes Chromosomes Cancer; 2021 Mar; 60(3):129-137. PubMed ID: 33099852
[TBL] [Abstract][Full Text] [Related]
14. Prognostic importance of vascular endothelial growth factor and its receptors in the uterine sarcoma.
Arita S; Kikkawa F; Kajiyama H; Shibata K; Kawai M; Mizuno K; Nagasaka T; Ino K; Nomura S
Int J Gynecol Cancer; 2005; 15(2):329-36. PubMed ID: 15823121
[TBL] [Abstract][Full Text] [Related]
15. Expression and prognostic value of lactate dehydrogenase-A and -D subunits in human uterine myoma and uterine sarcoma.
Song KJ; Yu XN; Lv T; Chen YL; Diao YC; Liu SL; Wang YK; Yao Q
Medicine (Baltimore); 2018 Apr; 97(14):e0268. PubMed ID: 29620641
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant radiotherapy shows benefit in selected stage I uterine sarcoma: A risk scoring system based on a population analysis.
Huang YX; Lin YZ; Li YM; Chu KX; Zhou YF; Lin LM; Zhou R; Zhang ZK; Lin Q
Cancer Med; 2022 Jul; 11(14):2846-2854. PubMed ID: 35277934
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Factors for Uterine Sarcoma and Carcinosarcoma: Insights from a 10-Year Follow-Up Study.
Kotowicz B; Dańska-Bidzińska A; Fuksiewicz M; Nasierowska-Guttmejer A; Raczkiewicz D; Gujski M; Piątek S; Bidziński M
Med Sci Monit; 2023 Dec; 29():e941562. PubMed ID: 38058118
[TBL] [Abstract][Full Text] [Related]
18. Levels of Circulating Fibroblast Growth Factor 23 (FGF23) and Prognosis in Cancer Patients with Bone Metastases.
Mansinho A; Ferreira AR; Casimiro S; Alho I; Vendrell I; Costa AL; Sousa R; Abreu C; Pulido C; Macedo D; Pacheco TR; Correia L; Costa L
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30736285
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and prognostic significance of chemokine receptor CXCR4 in patients with bone and soft tissue sarcoma: a meta-analysis.
Li YJ; Dai YL; Zhang WB; Li SJ; Tu CQ
Clin Exp Med; 2017 Feb; 17(1):59-69. PubMed ID: 26678086
[TBL] [Abstract][Full Text] [Related]
20. Research progress of fibroblast growth factor 23 in acute kidney injury.
Zhang L; Qin W
Pediatr Nephrol; 2023 Jul; 38(7):2013-2022. PubMed ID: 36416954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
